# Bioequivalence Study betweenYHP2407 and YHR2502 in Healthy Subjects

> **NCT06926387** · PHASE1 · COMPLETED · sponsor: **Yuhan Corporation** · enrollment: 43 (actual)

## Conditions studied

- Healthy Volunteer

## Interventions

- **DRUG:** YHP2407
- **DRUG:** YHR2502

## Key facts

- **NCT ID:** NCT06926387
- **Lead sponsor:** Yuhan Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-04-17
- **Primary completion:** 2025-04-19
- **Final completion:** 2025-04-29
- **Target enrollment:** 43 (ACTUAL)
- **Last updated:** 2025-05-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06926387

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06926387, "Bioequivalence Study betweenYHP2407 and YHR2502 in Healthy Subjects". Retrieved via MORVS 2026-10-17 from https://api.morvs.ai/clinical/NCT06926387. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*